| Sujata S Gaitonde, MD | |
|
1740 W Taylor St, Chicago, IL 60612-7232 | |
| (866) 600-2273 | |
| Not Available |
| Full Name | Sujata S Gaitonde |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 32 Years |
| Location | 1740 W Taylor St, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508972860 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 036106249 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Illinois Hospital | Chicago, IL | Hospital |
| Osf Saint Anthony Medical Center | Rockford, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Board Of Trustees Of The University Of Illinois | 3072422716 | 929 |
News Archive
The California Nurses Association/National Nurses Organizing Committee (CNA/NNOC) today applauds the Institute of Medicine for recommending strong patient safety protections for patients and caregivers to avoid airborne transmission during the ongoing H1N1/swine flu pandemic-and calls on the Centers for Disease Control to meet the same, stringent standards.
Just as the repeal positions of some big insurers are becoming more clear, more details on the Democrats' strategy to defend the law are emerging.
PTC Therapeutics, Inc. today announced that it has commenced a rolling submission of a New Drug Application to the United States Food and Drug Administration for Translarna™ for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD).
Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.
› Verified 7 days ago
| Entity Name | The Board Of Trustees Of The University Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386863819 PECOS PAC ID: 3072422716 Enrollment ID: O20031112000158 |
News Archive
The California Nurses Association/National Nurses Organizing Committee (CNA/NNOC) today applauds the Institute of Medicine for recommending strong patient safety protections for patients and caregivers to avoid airborne transmission during the ongoing H1N1/swine flu pandemic-and calls on the Centers for Disease Control to meet the same, stringent standards.
Just as the repeal positions of some big insurers are becoming more clear, more details on the Democrats' strategy to defend the law are emerging.
PTC Therapeutics, Inc. today announced that it has commenced a rolling submission of a New Drug Application to the United States Food and Drug Administration for Translarna™ for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD).
Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sujata S Gaitonde, MD 809 S Marshfield Ave, 9th Floor (m/c 732), Chicago, IL 60612-4305 Ph: (312) 996-7699 | Sujata S Gaitonde, MD 1740 W Taylor St, Chicago, IL 60612-7232 Ph: (866) 600-2273 |
News Archive
The California Nurses Association/National Nurses Organizing Committee (CNA/NNOC) today applauds the Institute of Medicine for recommending strong patient safety protections for patients and caregivers to avoid airborne transmission during the ongoing H1N1/swine flu pandemic-and calls on the Centers for Disease Control to meet the same, stringent standards.
Just as the repeal positions of some big insurers are becoming more clear, more details on the Democrats' strategy to defend the law are emerging.
PTC Therapeutics, Inc. today announced that it has commenced a rolling submission of a New Drug Application to the United States Food and Drug Administration for Translarna™ for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD).
Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.
› Verified 7 days ago
Mark Wang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St, Feinberg Pavilion, Chicago, IL 60611 Phone: 312-503-8144 Fax: 312-502-8249 | |
Sandeep Gurbuxani, Pathology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Katrina Krogh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St Ste 7-132i, Chicago, IL 60611 Phone: 312-926-7913 Fax: 312-926-3127 | |
Dr. Carmencita Garcia Senseng, MD Pathology Medicare: Medicare Enrolled Practice Location: 1900 W Polk St, Chicago, IL 60612 Phone: 312-864-7561 | |
Suman Setty, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Jayme Brentan, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Dr. Megan Elizabeth Sullivan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-926-3211 |